Abstract:Background The majority of autoimmune diseases, e.g. rheumatoid arthritis (RA), are characterized by autoantibodies that are produced by B cells. We have identified several novel post-translationally modified epitopes in collagen type II (CII), a major cartilage constituent that are autoreactive. In mouse models, autoantibodies that bind to these epitopes can either induce or protect against inflammatory arthritis. However, very little is known about the frequencies or phenotype the B cells that produce these autoantibodies in humans. Objectives The aim of this project is to study the B cells that produce autoantibodies reactive to CII-epitopes in patients with RA. Methods Clinical data and peripheral blood were collected from patients with RA (n=100). Titres of CII-reactive serum-autoantibodies were determined by Luminex. The different subsets of B cells that expressed a CII-reactive B cell receptor (BCR) were analysed and isolated in patients with positive (n=10) or negative (n=5) titres for autoantibodies recognizing the CII-epitopes cyc48 (CII-F4-R-Cit) and cyc49 (CII-F4-Cit-R) as well as in healthy controls (n=3) using flow cytometry. Results In patients with detectable autoantibodies to cyc48 and cyc49, their titres were 13761±3815 and 5585±1992 (mean ± SEM), respectively. The corresponding titres in the patients negative for these autoantibodies were 122±55 and 234±75. In autoantibody-positive patients, the frequencies of cells expressing a BCR reactive for cyc48 and cyc49 in different subsets were: transitional cells 0.88±0.18% and 1.33±0.33%; naïve cells 0.09±0.0008% and 0.13±0.06 and memory cells 0.31±0.25 and 0.30±0.12%. All frequencies were well above those detected in patients without cyc48/49 titres and in healthy controls. A higher proportion (p=0.03) of the cyc48/49 positive patients were treated with methotrexate compared to cyc48/49 negative patients, no other clinical differences were recorded. CII-reactive single B cells were isolated in order to clone the BCR Conclusions In patients with manifest RA there is a relatively high and detectable frequency of transitional B cells that express a joint-specific BCR, which suggests that the deletion of autoreactive B cells in the bone marrow in RA patients is defective. As there is a decrease in the proportion of naïve CII-specific B cells, a substantial amount of the autoreactive cells are deleted in the periphery. However, peripheral B-cell tolerance is incomplete, as CII-specific B cells are enriched in the pool of memory B cells. Disclosure of Interest None declared

Mice snRNP-Reactive B Cells in Autoimmune Cells: Characterization of La- and Identification of Autoantigen-Reactive B General Approach for Tetramer-Based

General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice

B cell subsets contributing to the autoreactive plasma cell pool in Lyn−/− mice

Isolation and functional analysis of autoreactive T cells from BXSB mice with murine lupus.

Correction: Antigen-presenting Autoreactive B Cells Activate Regulatory T Cells and Suppress Autoimmune Arthritis in Mice

Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients.

T‐bet‐expressing B cells contribute to the autoreactive plasma cell pool in Lyn‐/‐ mice

Interaction Between Antigen Presenting Cells and Autoreactive T Cells Derived from BXSB Mice with Murine Lupus

Increased PKC signaling in lupus La reactive B cells promotes development of the transitional T3 population and memory B cells in autoimmune BXD2 mice (BA3P.108)

Induction Of Nonpathologic, Humoral Autoimmunity In Lupus-Prone Mice By A Class Ii-Restricted, Transgenic Alpha Beta T Cell - Separation Of Autoantigen-Specific And -Nonspecific Help

Unveiling the Autoreactome: Proteome-wide Immunological Fingerprints Reveal the Promise of Plasma Cell Depleting Therapy.

Deciphering the Reactivity of Autoantibodies Directed against the RNP-A, -C and 70 kDa Components of the U1-snRNP Complex: "Double or Nothing"?

Lupus-associated innate receptors drive extrafollicular evolution of autoreactive B cells

SAT0031 Detection and Isolation of Antigen Specific B Cells in Patients with Rheumatoid Arthritis

Unveiling the Proteome-Wide Autoreactome Enables Enhanced Evaluation of Emerging CAR T Cell Therapies in Autoimmunity

Mapping epitopes of U1-70K autoantibodies at single-amino acid resolution

Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases

Identification of Major Histocompatibility Complex Class II Epitopes From Lyme Autoantigen Apolipoprotein B-100 and Borrelia burgdorferi Mcp4 in Murine Lyme Arthritis

Impact of TLR9 on Hyper-Responsive ITAM Signaling in a Mouse Model of SLE (47.24)

Role of Nucleic Acid-Sensing Tlrs in Diverse Autoantibody Specificities and Anti-Nuclear Antibody-Producing B Cells

Limited Biomarker Potential for IgG Autoantibodies Reactive to Linear Epitopes in Systemic Lupus Erythematosus or Spondyloarthropathy